9546 Ratios - Naba Alsaha Medical Services Co. | premargin

Sign In Sign Upعربي

Income Statement Balance Sheet Cash Flow Ratios

Annual Semi-annual Quarterly

Ratios

1-5

	H2 2025Dec 31, 2025	H1 2025Jun 30, 2025	H2 2024Dec 31, 2024	H1 2024Jun 30, 2024	H2 2023Dec 31, 2023
Market & Price
Market Capitalization	0.51B	0.70B	0.83B	1.09B	0.63B
Market Cap Growth	-38.0%	-35.6%	+31.7%	+116.7%	+109.3%
Enterprise Value	0.60B	0.75B	0.87B	1.13B	0.65B
Last Close Price	24.50	33.50	39.35	51.80	29.88
Valuation Multiples
PE Ratio	18.69	30.65	38.08	29.00	12.03
PS Ratio	2.55	3.59	4.27	5.55	3.46
PB Ratio	2.31	3.34	4.16	5.65	3.50
P/TBV Ratio	2.35	3.39	4.23	5.75	3.56
P/FCF Ratio	—	—	-453.74	—	—
P/OCF Ratio	19.20	20.56	23.28	30.47	21.46
EV/Sales Ratio	2.95	3.82	4.50	5.77	3.57
EV/EBITDA Ratio	14.15	22.09	25.44	23.45	12.62
EV/EBIT Ratio	18.42	30.29	34.60	28.45	14.83
EV/FCF Ratio	—	—	-478.14	—	—
Leverage & Capital
Debt / Equity Ratio	0.55	0.42	0.45	0.28	0.27
Debt / FCF Ratio	—	—	-48.78	—	—
Net Debt / Equity Ratio	0.47	0.39	0.23	0.23	0.24
Net Debt / EBITDA Ratio	2.46	2.40	1.35	0.92	0.82
Net Debt / FCF Ratio	-2.40	-2.72	-25.38	-2.41	-4.47
Returns & Yields
Return on Capital Employed (ROCE)	+8.9%	+7.9%	+8.4%	+15.9%	+19.0%
Earnings Yield	+5.4%	+3.3%	+2.6%	+3.4%	+8.3%
FCF Yield	-8.4%	-4.3%	-0.2%	-1.7%	-1.5%